EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective

Autor: Hernandez, LG, Paly, V, Li, S, Khanduri, P, Asfaw, AA, Zou, D
Zdroj: In Value in Health June 2024 27(6) Supplement:S106-S106
Databáze: ScienceDirect